These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16828780)

  • 1. Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
    Maas R; Quitzau K; Schwedhelm E; Spieker L; Rafflenbeul W; Steenpass A; Lüscher TF; Böger RH
    Atherosclerosis; 2007 Mar; 191(1):211-9. PubMed ID: 16828780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients.
    Mittermayer F; Schaller G; Pleiner J; Vychytil A; Sunder-Plassmann G; Hörl WH; Wolzt M
    J Am Soc Nephrol; 2005 Jun; 16(6):1832-8. PubMed ID: 15857920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH; Lentz SR; Bode-Böger SM; Knapp HR; Haynes WG
    Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
    Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
    Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.
    De Gennaro Colonna V; Bonomo S; Ferrario P; Bianchi M; Berti M; Guazzi M; Manfredi B; Muller EE; Berti F; Rossoni G
    Eur J Pharmacol; 2007 Feb; 557(2-3):178-85. PubMed ID: 17258196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).
    ENCORE Investigators
    Circulation; 2003 Jan; 107(3):422-8. PubMed ID: 12551866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance.
    Walker HA; McGing E; Fisher I; Böger RH; Bode-Böger SM; Jackson G; Ritter JM; Chowienczyk PJ
    J Am Coll Cardiol; 2001 Aug; 38(2):499-505. PubMed ID: 11499744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis.
    Antoniades C; Demosthenous M; Tousoulis D; Antonopoulos AS; Vlachopoulos C; Toutouza M; Marinou K; Bakogiannis C; Mavragani K; Lazaros G; Koumallos N; Triantafyllou C; Lymperiadis D; Koutsilieris M; Stefanadis C
    Hypertension; 2011 Jul; 58(1):93-8. PubMed ID: 21518967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Arginine is related to endothelium-dependent vasodilation in resistance and conduit arteries in divergent ways-The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
    Lind L; Larsson A; Teerlink T
    Atherosclerosis; 2009 Apr; 203(2):544-9. PubMed ID: 18757055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between plasma asymmetrical dimethylarginine and coronary artery disease].
    Song Y; Qu XF; Yu YW; Luan TZ; Li JJ; Guo H; Yu Y
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1527-30. PubMed ID: 17785101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
    Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
    Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
    Takiuchi S; Fujii H; Kamide K; Horio T; Nakatani S; Hiuge A; Rakugi H; Ogihara T; Kawano Y
    Am J Hypertens; 2004 Sep; 17(9):802-8. PubMed ID: 15363823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.